摘要
肠球菌已成为难以治疗的院内和社区获得性感染的主要原因之一。形成生物膜的肠球菌可以显著降低细菌对抗生素的敏感性,逃避宿主的免疫系统攻击,导致感染时间延长。因此开发新药物来应对抗肠球菌生物膜这一挑战是非常有必要的,本文就抗肠球菌生物膜的几种药物进行综述,以期为临床提供指导。
Enterococcus has become the main cause of hospital-acquired and community-acquired infections that are difficult to treat.The biofilm-forming Enterococcus can significantly reduce the sensitivity of bacteria to antibiotics and evade the host's immune system attack,resulting in prolonged infection time.Therefore,it is necessary to develop new drugs to deal with the challenge of Enterococcus biofilm.This article reviews several drugs against Enterococcus biofilm in order to provide guidance for clinical practice.
作者
曹阳
赵建平
Cao Yang;Zhao Jian-ping(Inner Mongolia Clinical Medical College,Inner Mongolia Medical University,Hohhot 010050;Department of Laboratory Medicine,Inner Mongolia People's Hospital,Hohhot 010000)
出处
《国外医药(抗生素分册)》
CAS
2023年第4期224-229,共6页
World Notes on Antibiotics
关键词
肠球菌
生物膜
抗感染
抗生物膜
新型药物
Enterococcus
biofilm
anti-infection
anti-biofilm
new chemotherapeutics